Blue Venture Fund

Abacus Insights, Inc. is a company that specializes in developing a cloud-based data integration and interoperability platform tailored for healthcare organizations. Founded in 2017 and headquartered in New York City, the company focuses on curating and organizing healthcare data from diverse sources and formats. Its platform facilitates the collection of both structured and unstructured enterprise-wide data, enabling healthcare companies to leverage advanced analytics for actionable insights. This capability helps improve the consumer experience, reduce care costs, and enhance the quality of care. Additionally, Abacus Insights provides maintenance and support services to its clients, ensuring the effective use of its data management solutions. The company also has an office in Boston, Massachusetts.

Waltz Health operates in the pharmaceutical supply chain, focusing on creating innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company develops consumer tools aimed at guiding decisions related to prescription care, with a particular emphasis on the needs of both payers and consumers. By utilizing AI-driven marketplaces, Waltz Health seeks to reduce costs and enhance the decision-making process for users. Their offerings provide better pricing information and resources that empower consumers while assisting payers in managing their pharmacy benefits more effectively.

Sempre Health, Inc. owns and operates a platform and offers behavior-based healthcare pricing to healthcare industry. The company works with health plans and pharmaceutical manufacturers to dynamically adjust a patient's co-payment based on individual adherence and behavior. It parses prescription records to predict the right price based on the patient's adherence to taking medicines in time. The company provides the patients access to their current discounts, why they got those discounts, and guidance on how to improve their health, via SMS. The company was founded in 2015 and is based in San Francisco, California.

CirrusMD Inc. operates a healthcare communication platform that enhances patient access to medical care in the United States. Founded in 2012 and based in Denver, Colorado, the CirrusMD platform allows patients to securely message doctors, send images, schedule video consultations, and access their health information at any time. The service emphasizes a text-first approach, enabling seamless communication between patients and local physicians through HIPAA-compliant channels. By facilitating direct messaging and video chats, CirrusMD aims to revolutionize the way patients receive frontline medical services, making healthcare more accessible and convenient.

Upward Health Inc. is a specialty care coordination organization that focuses on delivering integrated and home-based medical and behavioral care for individuals struggling with mental illness and substance abuse disorders. The company collaborates with health plans and healthcare providers to support high-risk patients, ensuring they receive comprehensive care tailored to their needs. By coordinating with caregivers, primary care physicians, and various medical and behavioral health specialists, Upward Health aims to facilitate recovery and help patients transition back into their communities effectively. Founded in 2017 and based in Providence, Rhode Island, Upward Health was previously known as BehaveCare Inc. before rebranding in July 2019.

Insightin Health develops a cloud-based platform that enhances preventative care recommendations for patients within healthcare systems. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the platform automates campaign management, allowing healthcare organizations to create personalized content and deliver it in real-time. By aggregating data from various sources, the system provides actionable analytics that helps organizations manage member activities effectively. Utilizing artificial intelligence, the platform combines medical, clinical, cognitive, and social determinants of health to suggest tailored next steps for individuals, thereby improving quality measures and member satisfaction while reducing churn. The company's services cater to Medicare/Medicaid, Accountable Care Organizations (ACOs), and other healthcare markets.

Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

Octave Bioscience is an early-stage molecular diagnostics company based in Menlo Park, California, that specializes in neurodegenerative diseases, particularly multiple sclerosis. Co-founded in 2013 by Melinda Thomas and William Hagstrom, the company has developed a clinical platform that generates, analyzes, and integrates data to transform the care of neurodegenerative conditions. This platform adopts a multi-dimensional approach aimed at reducing overall healthcare costs through the optimization of medication use and healthcare services. Additionally, Octave's technology supports the pharmaceutical industry by enhancing the drug discovery process, clinical trials, and post-marketing activities through real-world evidence.

Onc AI, founded in 2020 and based in San Carlos, California, specializes in clinical oncology and offers a precision oncology clinical management platform. The company focuses on enhancing decision-making in cancer care through a comprehensive approach that encompasses genomics, proteomics, and radiomics. By leveraging deep learning technologies, Onc AI aims to provide actionable insights that empower healthcare providers in the effective treatment of cancer.

PWNHealth, LLC is a New York-based company that specializes in lab connectivity, compliance, and patient outreach solutions. Founded in 2015, PWNHealth offers a cloud platform designed to facilitate consumer access to diagnostic testing across various sectors, including population health, telemedicine, consumer testing, life sciences, and diagnostic labs. The company operates a 50-state physician network that supports telehealth and telegenetics initiatives, enabling it to process over five million diagnostic screens annually. PWNHealth's technology solutions also assist clients in maintaining compliance with state and federal regulations, ensuring a seamless experience for patients seeking health and wellness services.

Owl Insights, Inc., is the provider of precision-guided behavioral care management technology for behavioral health. Through its advanced platform, affectionately termed “The Owl,” the company offers a scalable strategy to integrate measurement-based care and clinical analytics into existing behavioral health treatment workflows covering all major behavioral health conditions. Owl Insights supports health systems and independent behavioral health organizations nationwide to expand access, improve quality care delivery, better manage costs, and support the preparation for value-based care.

Somatus is a healthcare company that partners with health plans, health systems, and nephrology, and primary care groups. It provides integrated care for patients with or at risk of developing kidney disease. Somatus' is vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia, and founded by a team of world-class healthcare operators, successful entrepreneurs, and leading clinicians treating kidney disease.

Prove provides a phone-centric identity platform designed to enhance security and reduce fraud through the use of phone numbers. With over 1 billion identity tokens under management, Prove assists more than 1,000 companies and over 500 banks, including leading financial institutions, in securing their customer onboarding, digital services, and payment processes. The company offers two primary solutions: Prove Pre-fill™, which streamlines the onboarding process by authenticating consumer identities and auto-filling verified data, and Fonebook™, which provides a comprehensive identity authentication platform to manage customer phone numbers and create a unified customer view across various channels. Additionally, Prove offers multi-factor authentication options, including SMS and voice OTPs, instant link authentication, mobile authentication through cellular networks, voice biometrics, and app-based push authentication. These features enable secure transactions and enhance the overall customer experience across mobile, desktop, and in-store environments. Prove's services are available in 195 countries, underscoring its global reach in identity verification and fraud mitigation.

Abacus Insights, Inc. is a company that specializes in developing a cloud-based data integration and interoperability platform tailored for healthcare organizations. Founded in 2017 and headquartered in New York City, the company focuses on curating and organizing healthcare data from diverse sources and formats. Its platform facilitates the collection of both structured and unstructured enterprise-wide data, enabling healthcare companies to leverage advanced analytics for actionable insights. This capability helps improve the consumer experience, reduce care costs, and enhance the quality of care. Additionally, Abacus Insights provides maintenance and support services to its clients, ensuring the effective use of its data management solutions. The company also has an office in Boston, Massachusetts.

OncoHealth specializes in oncology benefits management solutions, offering services such as prior authorization, clinical decision support, physician education, expert peer review, and performance reporting. The company also features MATIS, a clinical decision support software designed for healthcare plans and providers, which enhances the analysis of cancer treatment and benefits management. Founded in 2009 and headquartered in Atlanta, Georgia, with an additional location in Plantation, Florida, OncoHealth employs a data-driven approach to help health plans, providers, and patients navigate oncology care. Its prior authorization platform supports approximately 5 million health plan members across the United States and Puerto Rico, addressing a comprehensive range of cancer treatments, including chemotherapy, radiation therapy, precision medicine, targeted therapy, and supportive care.

Perspectum Diagnostics Ltd. is a medical technology company based in Oxford, United Kingdom, with additional offices in Singapore and the United States. Founded in 2012, it specializes in developing innovative technologies for diagnosing and measuring liver diseases through advanced magnetic resonance imaging. The company's flagship product, LiverMultiScan, provides objective and quantitative assessments of liver health, aiding in the detection and measurement of liver, gallbladder, and pancreatic diseases, including precancerous and cancerous conditions. Perspectum's technologies are also utilized in clinical trials to evaluate investigational therapies for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. By focusing on precision medicine, Perspectum aims to enhance patient care through early detection, accurate diagnosis, and targeted treatment, leveraging a diverse team of experts in medicine and technology. As of March 2020, the company operates as a subsidiary of Ambra Health, Inc.

Contessa Health, Inc., based in Nashville, Tennessee, specializes in home hospitalization programs designed to enhance patient care while managing episodic risk. The company is recognized as a pioneer in Home Recovery Care, a risk-based model that integrates essential components of inpatient hospital care within patients' homes. Contessa employs a proprietary health informatics platform to support this model, ensuring that care is safe, affordable, and effective in improving patient outcomes. Additionally, Contessa offers solutions such as ContessaCare, which empowers healthcare providers to deliver hospital-level care at home, and ContradoClaim, a claims analytics tool that assists partners in managing prospective payments. The company also provides bundled payment managed services, enabling health plans and systems to optimize their care delivery without the need for hospital admissions. Contessa Health was founded in 2015 and continues to lead innovations in home-based healthcare.

Capson is a company based in Austin, Texas, that is transforming the medical malpractice insurance industry. Established in 2010, Capson emphasizes not only the policy aspects of medical insurance but also the overall experience for physicians and their patients. This approach allows clients to secure medical insurance at lower premiums while facilitating quicker claims resolutions. By prioritizing both coverage and user experience, Capson aims to enhance the relationship between medical professionals and their insurers.